Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Summary
This trial is studying PMS in order to comprehensively understand it, track how it develops, and identify possible biomarkers and genetic factors.
Eligible Conditions
- Autism Spectrum Disorder
- Autism
- Intellectual Disability
- Phelan-McDermid Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in adaptive behavior at 12 months
Change in adaptive behavior at 24 months
Change in autism symptoms at 12 months
+7 moreFind a Location
Who is running the clinical trial?
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,362 Previous Clinical Trials
650,560 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
280 Patients Enrolled for Autism Spectrum Disorder
Boston Children's HospitalLead Sponsor
778 Previous Clinical Trials
5,580,822 Total Patients Enrolled
21 Trials studying Autism Spectrum Disorder
5,200 Patients Enrolled for Autism Spectrum Disorder
National Center for Advancing Translational Sciences (NCATS)NIH
342 Previous Clinical Trials
410,278 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
443 Patients Enrolled for Autism Spectrum Disorder
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger